Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$1.80
-$0.21(-11.67%)
At close: 4:00 PM EDT
$1.80
-$0.21(-11.67%)
Day’s Range― - ―
52-Week Range$0.96 - $46.74
Previous Close$1.59
Volume1.23M
Average Volume (3M)7.54M
Market Cap
$26.93M
Enterprise Value$8.86M
Total Cash (Recent Filing)$26.07M
Total Debt (Recent Filing)$22.62M
Price to Earnings (P/E)―
Beta0.10
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.97%
Share Statistics
EPS (TTM)-123.08
Shares Outstanding19,517,834
10 Day Avg. Volume4,569,660
30 Day Avg. Volume7,542,317
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)22.88
Price to Sales (P/S)1.43
P/FCF Ratio-1.14
Enterprise Value/Market Cap0.33
Enterprise Value/Revenue-0.29
Enterprise Value/Gross Profit-1.08
Enterprise Value/Ebitda-0.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy Patient ServicesSRx’s core business centers on specialty pharmacy dispensing and patient support for complex therapies, a structurally growing area of healthcare. These services create recurring touchpoints with prescribers, payors and patients, making revenues stickier and building operational barriers to entry if the company achieves scale.
Restored NYSE Compliance And LiquidityRegaining full NYSE American compliance materially reduces delisting risk and restores public-market credibility. That stability improves access to capital markets, supports investor confidence, and makes future financings or strategic transactions less encumbered by listing-related constraints over the medium term.
Strategic Diversification Via AI And Crypto AssetsThe acquisition of EMJ Crypto and pivot to an AI-driven capital-allocation model diversifies revenue and asset bases, potentially creating asset-backed returns and new income streams. If executed well, this strategic shift can reduce reliance on a single healthcare operating model and create long-term optionality.
Bears Say
Persistent Net Losses And Negative Cash FlowThe company shows recurring, sizable net losses and predominantly negative operating and free cash flow, indicating the core operations have not consistently self-funded. Over the medium term this increases financing dependence, constrains reinvestment in operations, and raises execution and solvency risk absent sustained profit improvement.
Balance-sheet Volatility And High LeverageHistorical swings in leverage and thin equity buffers—extreme debt-to-equity in prior years—signal a balance sheet in repair rather than durable strength. This volatility reduces financial flexibility, elevates refinancing and covenant risks, and limits capacity to fund operations or strategic investments without dilutive financing.
Major Dilution And Complex Capital StructureThe large issuance of common and exchangeable shares plus pre-funded warrants, alongside Series B convertibles and warrants, materially reshapes capitalization. This dilution and added hybrid instruments increase governance and integration complexity, weaken incumbent shareholder claims, and heighten execution risk for long-term strategy.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.96 and its highest was $46.74 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $26.93M.
When is SRx Health Solutions’s upcoming earnings report date?
SRx Health Solutions’s upcoming earnings report date is May 20, 2027 which is in 289 days.
How were SRx Health Solutions’s earnings last quarter?
Currently, no data Available
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions pays a Notavailable dividend of $0.05 which represents an annual dividend yield of 3.97%. See more information on SRx Health Solutions dividends here
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 19,517,834 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SRx Health Solutions
SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. The company is headquartered in Tampa, Florida.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
8.38% Insiders
0.56% Mutual Funds
― Other Institutional Investors
55.36% Public Companies and
Individual Investors